Lower Urinary Tract Dysfunction and Training Intensity in Female Student Athletes
NCT07931118, Active not recruiting, Istanbul Galata University
Trial 8
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Lower Urinary Tract Dysfunction and Training Intensity in Female Student Athletes | ClinicalTrials.gov |
| NCT number | NCT07931118 | ClinicalTrials.gov |
| Status | Active not recruiting | ClinicalTrials.gov |
| Enrollment | 120 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Istanbul Galata University | ClinicalTrials.gov |
| Conditions | Lower Urinary Tract Dysfunction, Lower Urinary Tract Symptoms (LUTS), Female Athletes | ClinicalTrials.gov |
| First posted | 2026-11-12 | ClinicalTrials.gov |
| Last updated | 2026-11-12 | ClinicalTrials.gov |
Registered outcomes 7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Urogenital Distress Inventory (UDI-6) | Day 1 (Single assessment at one time point during participation) | self-administered Likert-type questionnaire designed to evaluate the presence and severity of lower urinary tract dysfunction symptoms.Total scores range from 0 to 18, and are converted into percentages for interpretation. Higher scores indicate more severe symptoms and a greater negative impact on quality of life. | ClinicalTrials.gov |
| Primary | International Consultation on Incontinence Questionnaire- Short Form (ICIQ- SF) | Day 1 (Single assessment at one time point during participation) | Used to assess the impact of urinary incontinence on quality of life and treatment need. It includes four items addressing the frequency of urinary incontinence, Amount of leakage, Overall impact on daily life and Self-diagnostic item. Scores range from 0 to 21, with higher scores indicating more severe symptoms and greater impairment of quality of life. | ClinicalTrials.gov |
| Primary | Contentment with Life Assessment Scale (CLAS) | Day 1 (Single assessment at one time point during participation) | The scale consists of 5 items rated on a 7-point Likert scale (1 = strongly disagree to 7 = strongly agree). Higher scores indicate greater life satisfaction. | ClinicalTrials.gov |
| Secondary | Body Mass Index (BMI) | Day 1 (Single assessment at one time point during participation) | Calculated as weight (kg) / height² (m²). Classified according to WHO standards. | ClinicalTrials.gov |
| Secondary | Demographic and training characteristics checklist | Day 1 (Single assessment at one time point during participation) | Collected using a custom-designed questionnaire including: Demographic data (date of birth, academic department, year of study, body weight, height, sports branch, age of starting the sport) Training information (weekly frequency, duration, and intensity) | ClinicalTrials.gov |
| Other | Competition participation and achievements checklist | Day 1 (Single assessment at one time point during participation) | Type and level of competitions, national team status, awards within the past year | ClinicalTrials.gov |
| Other | Lifestyle and menstrual health variables | Day 1 (Single assessment at one time point during participation) | Collected using self-report questions assessing daily activity level, sitting time, sleep duration and quality, fluid intake, menstrual regularity, and stress levels. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 4
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.3.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 4a570df2e7274cee2d4fa2959402fab41880e2cd412e4b590390035fbea69391 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
Release trials-2026-11-12-0.3.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.